Cell Cycle Inhibition To Target The Evolution Of Urothelial Cancer (Clonevo): A Single-Arm, Open-Label Window-Of-Opportunity Trial Of Neoadjuvant Abemaciclib In Platinum-Ineligible Muscle Invasive Bladder Cancer Patients

Jones Nauseef,Panagiotis J. Vlachostergios,Ana M. Molina,David M. Nanus,Cora N. Sternberg,Timothy D. Mcclure,Douglas Scherr,M. Laura Martin,Giorgio Inghirami,Olivier Elemento,Scott T. Tagawa,Bishoy Morris Faltas

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 1|浏览55

暂无评分

摘要

TPS606Background: The standard of care for clinically localized muscle-invasive bladder cancer (MIBC) is neoadjuvant platinum-based combination chemotherapy followed by radical cystectomy (RC). Up ...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要